Receiving Helpdesk

how many units of insulin are in a vial of novolog

by Alysson Braun Published 4 years ago Updated 2 years ago

NovoLog FlexTouch Pen (“Pen”) is a prefilled disposable pen containing 300 units of U-100 NovoLog (insulin aspart injection) insulin. You can inject from 1 to 80 units in a single injection. The units can be increased by 1 unit at a time.

Dosage Forms And strengths
Injection: 100 units/mL (U-100) is a clear and colorless solution available as: 10 mL multiple-dose vial.

Full Answer

How many units of insulin are in a NovoLog pen?

Each NovoLog® FlexPen® package has 5 disposable insulin pens, for a total of 1500 units of NovoLog® insulin. Saving on NovoLog® FlexPen® NovoLog® FlexPen® is covered by most health care and Medicare prescription plans. You can get NovoLog® FlexPen® for about the same co Continue reading >>

What are the guidelines for using NovoLog vials?

Warnings and Precautions Never Share a NovoLog® FlexPen, NovoLog® FlexTouch, PenFill®Cartridge, or PenFill®Cartridge Device Between Patients, even if the needle is changed. Patients using NovoLog® vials must never share needles or syringes with another person.

Can NovoLog be mixed with other insulins?

NovoLog should not be mixed with other insulins or with a diluent when it is used in the pump (2.3). Intravenous use: NovoLog should be used at concentrations from 0.05 U/mL to 1.0 U/mL insulin aspart in infusion systems using polypropylene infusion bags.

How many units are in a vial of insulin?

Humalog insulin comes in 3 mL (300 units) vials or 10 mL (1000 units) vials. All other types of insulin come in 10 mL (1000 units) vials. Insulin pens or cartridges come in boxes of five 3 mL pens or cartridges. Insulin syringes come in three different sizes. The size of the syringe depends on your insulin dose.

How many units of insulin are in a vial?

A typical vial of insulin contains 10 mL, or 1,000 "units" of insulin. Based on customer feedback and the average length of stay in the hospital for patients with diabetes, Lilly developed this new option to help meet the needs of hospital customers.

How much insulin is in a vial of NovoLog?

NovoLog is a sterile, aqueous, clear, and colorless solution, that contains insulin aspart 100 Units/mL, glycerin 16 mg/mL, phenol 1.50 mg/mL, metacresol 1.72 mg/mL, zinc 19.6 mcg/mL, disodium hydrogen phosphate dihydrate 1.25 mg/mL, sodium chloride 0.58 mg/mL and water for injection. NovoLog has a pH of 7.2-7.6.

How much is 100 units of NovoLog?

The cost for Novolog injectable solution (100 units/mL) is around $314 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

How long does a vial of NovoLog last?

After diluting insulin aspart (Novolog), you can keep it at room temperature for 28 days. After diluting insulin lispro (Humalog) you can keep it refrigerated for 28 days or at room temperature up to 86°F for 14 days.Dec 16, 2021

How do I calculate how much insulin to take?

Add up all the carbohydrates in your meal. Divide the total carbohydrates by the insulin to carbohydrate ratio. The result is the amount of insulin units needed.

How is novolog dosed?

Adult patients start NovoLog® dose at their largest meal of the day, only 1 meal each day. They must take their dose 5 to 10 minutes before eating.

How many units are in NovoLog FlexPen?

NovoLog FlexPen is a prefilled disposable device that looks like a pen. It contains 300 units of U-100 NovoLog insulin.

How much is NovoLog per box?

The current list price for a 10 mL vial of NovoLog is $289.36, compared with Walmart's $72.88 cash price. The current list price for a five-pen box of NovoLog FlexPen is $558.83, compared with Walmart's $85.88 cash price.Jun 30, 2021

How much does NovoLog vial cost without insurance?

With coverage, you could pay $333 or more per refill. Without coverage, Novolog costs approximately $371.24. Use your instant savings card from SingleCare and compare your price with our Novolog coupons, which is $159.61 for 1, 10ML of 100UNIT/ML Solution, to your Medicare discount.

Does NovoLog vial need to be refrigerated?

Refrigerated (36ºF-46ºF) Unused (unopened) product inadvertently left at room temperature can be returned to refrigeration but must be used within designated days of initially being stored at room temperature. Once in use, Novolin® vials and Novolin®/ReliOn® vials should not be refrigerated.

How many vials of insulin do I need a month?

Diabetics typically require two to four vials of insulin a month, sometimes more, so it's easy to see how a patient with no insurance or a high deductible could have to pay at least $1,000 for a month's supply.Dec 6, 2021

Does NovoLog need refrigeration?

You should keep your unopened Novolog Flexpen out of the light and refrigerated between 36 and 46 degrees Fahrenheit. Do not freeze it. Once opened, store your Novolog Flexpen at room temperature (up to 85 degrees Fahrenheit) for as long as 28 days. Do no refrigerate opened Flexpens.

How many units of NovoLog insulin are in a pack?

Each NovoLog® FlexPen® package has 5 disposable insulin pens, for a total of 1500 units of NovoLog® insulin.

What is Novolog injection?

NOVOLOG - insulin aspart injection, solution Novo Nordisk Inc. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG (insulin aspart) injection, solution for intravenous and subcutaneous use Initial U.S. Approval: 2000 INDICATIONS AND USAGE NovoLog is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus (1.1). DOSAGE AND ADMINISTRATION The dosage of NovoLog must be individualized. Subcutaneous injection: NovoLog should generally be given immediately (within 5-10 minutes) prior to the start of a meal (2.2). Use in pumps: Change the NovoLog in the reservoir, the infusion set, and the infusion set insertion site at least every 48 hours. NovoLog should not be mixed with other insulins or with a diluent when it is used in the pump (2.3). Intravenous use: NovoLog should be used at concentrations from 0.05 U/mL to 1.0 U/mL insulin aspart in infusion systems using polypropylene infusion bags. NovoLog has been shown to be stable in infusion fluids such as 0.9% sodium chloride (2.4). DOSAGE FORMS AND STRENGTHS Each presentation contains 100 Units of insulin aspart per mL (U-100) 10 mL vials (3) 3 mL PenFill® cartridges for the 3 mL PenFill cartridge device (3) 3 mL NovoLog FlexPen Prefilled syringe (3) CONTRAINDICATIONS Do not use during episodes of hypoglycemia (4). Do not use in patients with hypersensitivity to NovoLog or one of its excipients. WARNINGS AND PRECAUTIONS Hypoglycemia is the most common adverse effect of insulin therapy. Glucose monitoring is recommended for all patients with diabetes. Any change of insulin dose should be made cautiously and only under medical supervision (5.1, 5. Continue reading >>

How do insulin pen devices help?

The advantages offered by insulin pens may help improve patient adherence. Currently 8.3% of the United States adult population, or 25.8 million people, have diabetes. Of these cases, more than 90% are cases of type 2 diabetes mellitus (T2DM) and at least 1 million are estimated to be cases of type 1 diabetes mellitus (T1DM). Although a variety of oral medications are available for patients with diabetes, insulins remain an important component of treatment.1,2 Insulins are the standard therapy in patients with T1DM and are ultimately used in patients with T2DM who do not respond adequately to other treatment modalities. Although in some settings insulins may be administered intravenously (eg, with an insulin pump), the vast majority of insulin administrations are subcutaneous injections.1,2 Available Forms and Administration In the United States, 2 types of insulins are available: recombinant human insulins and insulin analogs. Recombinant human insulin is available from 2 manufacturers (Humulin by Eli Lilly and Novolin by Novo Nordisk); each of these is available in a regular form and in a longer-acting neutral protamine hagedorn (NPH) form. Unlike recombinant human insulins, insulin analogs are structurally modified forms of insulin that are designed to either lower blood sugar rapidly or maintain low blood sugar levels over time. These insulin analogs may be classified as rapid-acting and long-acting insulins. Rapid-acting insulins include insulin lispro, insulin aspart, and insulin glulisine, and long-acting insulins include insulin glargine and insulin detemir. Premixed formulations of insulin are also available.1,2 Regardless of the differences between insulin formulations, all conventional types of insulin can be administered subcutaneously. Subcutaneous injectio Continue reading >>

What is the best medication for diabetes?

Novolog. Novolog is a prescription medication used to treat type 1 and type 2 diabetes. Novolog is a fast-acting form of insulin. It is usually given with a long-acting insulin to provide a steady amount of insulin to control blood glucose (sugar) levels.

How much is a 10ml val?

NovoLog/NovoRapid (Insulin Aspart) Vials 10 mL QTY TYPE PRICE COST PER UNIT 1 10 mL Vial $80.91 $80.91 2 10 mL Vial $125.80 $62.90 3 10 mL Vial $170.67 $56.89 4 10 mL Vial $215.56 $53.89 5 10 mL Vial $260.45 $52.09 6 10 mL Vial $305.34 $50.89 7 10 mL Vial $350.21 $50.03 8 10 mL Vial $395.12 $49.39 9 10 mL Vial $442.53 $49.17 10 10 mL Vial $484.90 $48.49 VIEW ALL INSULIN PRODUCTS PLACE A NEW INSULIN ORDER What is NovoLog Vial? NovoLog, known as NovoRapid in Canada, contains insulin aspart, which is a fast-acting mealtime insulin. Insulin aspart is a man-made insulin that is similar to naturally occurring human insulin. Only a single amino acid has been modified, compared to the structure of human insulin (which consists of 51 amino acids in total). This small change allows this medication to be absorbed quickly. It starts to work in minutes, which lets you eat soon after its administration. What is it used for? NovoLog is used for the control of blood sugar levels in adults and children with diabetes. It has a relatively low likelihood of causing hypoglycemia, which is low blood sugar, the most common side effect of insulin therapy. How does it work? NovoLog is a type of mealtime or bolus insulin, which works quickly to regulate blood sugar levels during and after eating. You can start to eat within 5 to 10 minutes after taking it, with its peak action taking effect between 45 to 90 minutes, while lasting approximately 3 to 5 hours. These times are based on averages and can vary due to which injection site you use, the temperature of the medication, your blood flow and exercise. NovoLog is similar in structure to naturally occurring insulin and works similarly, too. Naturally occurring insulin is a hormone produced in a large organ near the stomach called the pancreas. I Continue reading >>

What is the difference between humalog and novolog?

Humalog is the brand-name version of insulin lispro, and Novolog is the brand-name version of insulin aspart. These drugs both help control blood glucose (sugar) in people with type 1 and type 2 diabetes. Humalog and Novolog are both rapid acting. That means they work more quickly than other types of insulin.

How many units of insulin are in a milliliter?

The dose is how many units of insulin you will use. The concentration tells how many units of insulin are in each milliliter (mL), such as 100 units/mL (U-100), but this does not mean you will use 100 units at a time.

What is the billing unit for Novolog?

Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume. Dosage Form Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. The NDC Code 0169-7501-11 is assigned to Novolog, a human prescription drug labeled by Novo Nordisk. The product's dosage form is injection, solution and is administered via intravenous; subcutaneous form. Code Structure The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product. * Please review the disclaimer below. This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. NDC 0169-7501-11 HCPCS crosswalk information with package details and bill units information. * Please review the disclaimer below. Continue reading >>

What is a Novolog?

Novolog. Novolog is a prescription medication used to treat type 1 and type 2 diabetes. Novolog is a fast-acting form of insulin. It is usually given with a long-acting insulin to provide a steady amount of insulin to control blood glucose (sugar) levels. This medication comes in an injectable form available in vials and prefilled pens.

What is the drug name for insulin aspart?

Prescription Drugs Search or browse for information on Prescription Drugs Brand Name NovoRapid Common Name insulin aspart In this drug factsheet: DIN (Drug Identification Number) How does this medication work? What will it do for me? Insulin is a naturally occurring hormone made by the pancreas that helps our body use or store the glucose (sugar) it gets from food. For people with diabetes, either the pancreas does not make enough insulin to meet the body's requirements, or the body cannot properly use the insulin that is made. As a result, glucose cannot be used or stored properly and accumulates in the bloodstream. Insulin injected under the skin helps to lower blood glucose levels. There are many different types of insulin and they are absorbed at different rates and work for varying periods of time. Insulin aspart is a rapid-acting insulin. It takes 10 to 20 minutes to begin working after the injection, has its maximum effect between 1 hour and 3 hours, and stops working after 3 to 5 hours. Insulin aspart should be used along with an intermediate or long-acting insulin. This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here. Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given this medication, speak to your doctor. Do not stop using this medication without consulting your doctor. Do not give this medication to anyone else, even if they have th Continue reading >>

How long does it take for insulin to work?

Insulin aspart is a rapid-acting insulin. It takes 10 to 20 minutes to begin working after the injection, has its maximum effect between 1 hour and 3 hours, and stops working after 3 to 5 hours.

How long has it been since you started using insulin?

It has been more than 28 days since you began using the vial, pen, or cartridge. Put a label on your pen, vial, or cartridge with date opened. Insulin vials have U-100 insulin. That means there are 100 units of insulin in each milliliter (mL) of insulin.

What are the side effects of Novolog?

Common side effects of Novolog include low blood sugar, reaction at the injection site, and weight gain. Novolog is a prescription medication used to control high blood sugar in adults and children with type 1 or type 2 diabetes. This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

What is the risk of sharing insulin?

Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia.

How many units of NovoLog insulin are in a pack?

Each NovoLog® FlexPen® package has 5 disposable insulin pens, for a total of 1500 units of NovoLog® insulin.

What is the difference between humalog and novolog?

Humalog is the brand-name version of insulin lispro, and Novolog is the brand-name version of insulin aspart. These drugs both help control blood glucose (sugar) in people with type 1 and type 2 diabetes. Humalog and Novolog are both rapid acting. That means they work more quickly than other types of insulin.

How much insulin should I take for diabetes mellitus?

Type 1 Diabetes Mellitus Improvement of glycemic control in adults and children with diabetes mellitus May administer 0.2-0.6 unit/kg/day in divided doses; conservative doses of 0.2-0.4 unit/kg/day often recommended to reduce risk of hypoglycemia Total maintenance daily insulin requirement may vary; it is usually between 0.5 and 1 unit/kg/day; nonobese may require 0.4-0.6 unit/kg/day; obese may require 0.6-1.2 units/kg/day Type 2 Diabetes Mellitus Diabetes inadequately controlled by diet, weight reduction, exercise, or oral medication 10 units/day SC (or 0.1-0.2 units/kg/day) in evening or divided q12hr of an intermediate (eg, NPH) or long-acting insulin at bedtime recommended; conversely, regular insulin or rapid-acting insulin (aspart insulin) before meals also recommended Dosing Considerations When used in a meal-related SC injection treatment regimen, 50-75% of total insulin requirements may be provided by an intermediate-acting or long-acting insulin; the remainder is divided and provided before or at mealtimes as a rapid-acting insulin, such as insulin aspart Because of insulin aspart’s comparatively rapid onset and short duration of glucose-lowering activity, some patients may require more basal insulin and more total insulin to prevent premeal hyperglycemia than they would need when using human regular insulin Dosage must be individualized; blood and urine glucose monitoring is essential in all patients receiving insulin therapy Insulin requirements may be altered during stress or major illness or with changes in exercise, meal patterns, or coadministered drugs Dosage Modifications Patients with hepatic and renal impairment may be at increased risk of hypoglycemia and may require more frequent dose adjustment and more frequent blood glucose monitoring Continue reading >>

What is insulin aspart used for?

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes . Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.

What is a Novopen Junior?

NovoPen Junior is a line extension of the company's NovoPen®, the most widely used insulin pen in the world. "NovoPen Junior fills an important need among children and young adults because it allows half-unit dosing," said Harold Starkman, MD, at the Pediatric Diabetes Center, Morristown Memorial Hospital, Morristown, NJ. He explained that, because of their small body size, many children with diabetes require only small amounts of insulin to maintain proper control — with some requiring very finely tuned doses. "NovoPen Junior allows people with diabetes, particularly children and young adults, to administer insulin more accurately to meet their needs," he said. Dr. Starkman said that the incidence of diabetes is increasing dramatically in children. "It's more important than ever before to make insulin therapy as easy and as accurate as possible for those who need it," he said. He added that the bright and colorful look of NovoPen Junior may encourage children to more easily accept and incorporate a daily insulin regimen into their lives. NovoPen Junior is available in two fun colors, to help patients tell their different insulin types apart. Insulin therapy is administered with NovoPen Junior by dialing the dose, inserting the needle, and pushing the injection button. The dosage dial is graduated in half-unit markings and can administer from one to 35 units. NovoPen Junior is designed for use with Novo Nordisk's range of PenFill® 3 mL cartridges, which contain 300 units of insulin. It is used with NovoFine® disposable needles, including NovoFine 31-gauge (6 mm) needles, whose design may help make insulin injections more comfortable. NovoPen Junior is available as part of a complete diabetes management system. The NovoPen® Junior Diabetes Management System include Continue reading >>

Why is Novopen Junior so colorful?

He added that the bright and colorful look of NovoPen Junior may encourage children to more easily accept and incorporate a daily insulin regimen into their lives. NovoPen Junior is available in two fun colors, to help patients tell their different insulin types apart.

Why do people need insulin pen?

Insulin Pens: How To Give A Shot. Many people with diabetes need to take insulin to keep their blood glucose in a good range. This can be scary for some people, especially for the first time. The truth is that insulin shots are not painful as people imagine because the needles are short and thin.

Can you take Novolog with type 1 diabetes?

NovoLog®has not been studied in children with type 2 diabetes or in children with type 1 diabetes who are younger than 2 years of age. Like all insulins, NovoLog®requirements may be reduced in patients with renal impairment or hepatic impairment.

Can NovoLog cause anaphylaxis?

Severe, life-threatening, generalized allergy, including anaphylaxis, may occur with insulin products, including NovoLog®. As with all insulins, NovoLog®use can lead to life-threatening hypokalemia, which then may cause respiratory paralysis, ventricular arrhythmia, and death.

Can insulin change glycemic control?

Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen:Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, or injection site or method of administration) may affect glycemic control and predispose to hypo glycemia or hyperglycemia.

Is hypoglycemia a side effect of insulin?

Hypoglycemia is the most common adverse effect of insulin therapy. The timing of hypoglycemia may reflect the time-action profile of the insulin formulation. Glucose monitoring is recommended for all patients with diabetes and is particularly important for patients using external pump infusion therapy.

Insulin pump

NovoLog ® is approved for use in insulin pumps in children ages 2 and older with type 1 diabetes and adults with type 1 and type 2 diabetes. An insulin pump is a small, programmable, battery-operated device that delivers a steady, measured amount of insulin under your skin.

Learn about another rapid-acting insulin

Get details on another rapid-acting insulin from Novo Nordisk that is also available in pens and can be used in a pump.

How much insulin should I take for diabetes mellitus?

Type 1 Diabetes Mellitus Improvement of glycemic control in adults and children with diabetes mellitus May administer 0.2-0.6 unit/kg/day in divided doses; conservative doses of 0.2-0.4 unit/kg/day often recommended to reduce risk of hypoglycemia Total maintenance daily insulin requirement may vary; it is usually between 0.5 and 1 unit/kg/day; nonobese may require 0.4-0.6 unit/kg/day; obese may require 0.6-1.2 units/kg/day Type 2 Diabetes Mellitus Diabetes inadequately controlled by diet, weight reduction, exercise, or oral medication 10 units/day SC (or 0.1-0.2 units/kg/day) in evening or divided q12hr of an intermediate (eg, NPH) or long-acting insulin at bedtime recommended; conversely, regular insulin or rapid-acting insulin (aspart insulin) before meals also recommended Dosing Considerations When used in a meal-related SC injection treatment regimen, 50-75% of total insulin requirements may be provided by an intermediate-acting or long-acting insulin; the remainder is divided and provided before or at mealtimes as a rapid-acting insulin, such as insulin aspart Because of insulin aspart’s comparatively rapid onset and short duration of glucose-lowering activity, some patients may require more basal insulin and more total insulin to prevent premeal hyperglycemia than they would need when using human regular insulin Dosage must be individualized; blood and urine glucose monitoring is essential in all patients receiving insulin therapy Insulin requirements may be altered during stress or major illness or with changes in exercise, meal patterns, or coadministered drugs Dosage Modifications Patients with hepatic and renal impairment may be at increased risk of hypoglycemia and may require more frequent dose adjustment and more frequent blood glucose monitoring Continue reading >>

How does insulin aspart work?

Proper control of diabetes may also lessen your risk of a heart attack or stroke.Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Read the Patient Information Leaflet provided by your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor, diabetes educator, or pharmacist.Learn all preparation and usage instructions from your health care professional and the product package.Before using, check this product visually for particles or discoloration. If either is present, do not use the insulin. Insulin aspart should be clear and colorless.Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin (lipodystrophy). Insulin aspart may be injected in the stomach area, the thigh, or the back of the upper arm. Do not inject into skin that is red, swollen, or itchy. Do not inject cold insulin because this can be painful. The insulin container you are currently using can be kept at room temperature.Inject this medication under the skin as directed by your doctor. Some brands should be injected 5 to 10 minu Continue reading >>

Can you take Novolog 70/30 with other people?

Do not share your NovoLog® Mix 70/30 FlexPen® with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them. Who should not take NovoLog® Mix 70/30? Do not take NovoLog® Mix 70/30 if: your blood sugar is too low (hypoglycemia) or you are allergic to any of its ingredients. Before taking NovoLog® Mix 70/30, tell your healthcare provider about all your medical conditions including, if you are: pregnant, planning to become pregnant, or are breastfeeding. taking new prescription or over-the-counter medicines, including supplements. Talk to your health care provider about how to manage low blood sugar. How should I take NovoLog® Mix 70/30? Read the Instructions for Use and take exactly as directed. NovoLog® Mix 70/30 starts acting fast. If you have type 1 diabetes, inject within 15 minutes before you eat a meal. If you have type 2 diabetes, inject within 15 minutes before or after starting your meal. Do not mix NovoLog® Mix 70/30 with other insulin products or use in an insulin pump. Know the type and strength of your insulin. Do not change your insulin type unless your health care provider tells you to. Check your blood sugar levels. Ask your health care provider what your blood sugar levels should be and when you should check them. Do not reuse or share your needles or syringes with other people. You may give other people a serious infection, or get a serious infection from them. What should I avoid while taking NovoLog® Mix 70/30? Do not drive or operate heavy machinery, until you know how NovoLog® Mix 70/30 affects you. Do not drink alcohol or use medicines that contain alcohol. What are the possible side effects of NovoLog® Mix 70/30? Serious side effects can lead to death, includin Continue reading >>

Is Novolog 70/30 a contraindication?

NovoLog® Mix 70/30 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® Mix 70 /30 or one of its excipients. Never Share a NovoLog® Mix 70/30 FlexPen® Between Patients, even if the needle is changed. Patients using NovoLog® Mix 70/30 vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia. Changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL Indications and Usage NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in patients with diabetes mellitus. NovoLog® Mix 70/30 is not recommended for the treatment of diabetic ketoacidosis. The proportions of rapid-acting and long-acting insulins are fixed and do not allow for basal versus prandial dose adjustments. NovoLog® Mix 70/30 is contraindicated during episodes of hypoglycemia and in patients hypersensitive to NovoLog® Mix 70/30 or one of its excipients. Never Share a NovoLog® Mix 70/30 FlexPen® Between Patients, even if the needle is changed. Patients using NovoLog® Mix 70/30 vials must never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens. Changes in insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or Continue reading >>

How much is Novolog?

pharmacies. The cost for Novolog injectable solution (100 units/mL) is around $296 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans. Novolog is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Novolog availability. Injectable Solution Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Drugs.com Printable Discount Card Print Now The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions. Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide. Novolog Coupons and Rebates Novolog offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office. NovoLog Instant Savings Card: Eligible patients may pay no more than $25 per prescription for NovoLog plus up to 2 years of additional savings on other Novo Nordisk products; also receive 1 FREE box of needles wi Continue reading >>

How effective is Novolog?

NovoLog® has been proven safe and effective for use in insulin pumps in children ages 2 and older with type 1 diabetes and adults with type 1 and type 2 diabetes. Many people with type 1 diabetes use an insulin pump. What is an insulin pump? An insulin pump is a small, programmable, battery-operated device that delivers a steady, measured amount of insulin under your skin. You and your diabetes care team can program your insulin pump to deliver NovoLog® in constant “basal” doses throughout the day and “bolus” doses at mealtime. Insulin pumps may be helpful for people with diabetes who have more than one insulin injection per day, including some people with type 2 diabetes. Pumps provide continuous insulin delivery in small doses, similar to the way the pancreas naturally releases basal insulin. You push a button to release mealtime doses of insulin to cover food. They allow people with diabetes to take their insulin automatically, wherever they happen to be. Benefits of NovoLog® in an insulin pump NovoLog® is a fast-acting insulin that can be used for up to 6 days in a pump before it needs to be changed. The table below shows how often to change NovoLog® in a pump. Please be sure to check the instructions that came with your pump. Pump component Time frame before changing NovoLog® in reservoir Up to 6 days Infusion set and infusion set insertion site Up to 3 days NovoLog® in the pump should be discarded after exposure to temperatures that exceed 98.6ºF. Low rate of clogs in an insulin pump In a clinical study, NovoLog® was found to have a low rate of clogs when used in pumps. That's good news if you are already using, or thinking about using, an insulin pump. NovoLog® remains heat stable in pumps at normal body temperature (up to 98.6°F). This makes N Continue reading >>

How does insulin aspart work?

In patients with type 1 diabetes, insulin aspart is usually used with another type of insulin, unless it is used in an external insulin pump. In patients with type 2 diabetes, insulin aspart also may be used with another type of insulin or with oral medication (s) for diabetes. Insulin aspart is a short-acting, manmade version of human insulin. Insulin aspart works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication (s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes. Insulin aspart comes as a solution (liquid; Fiasp, NovoLog) and Continue reading >>

What is the most common way to inject diabetes medicine?

Millions of Americans are living with it. And of those, about 15% use medicine that’s injected. Vials and syringes used to be the most common way to inject. But today, many injectable diabetes medicines come in prescription pens, also called prefilled pens. Here, we will focus on the needles that are used with those pens. Choosing a pen needle Today's pen needles are designed to fit most prefilled pens. But, there are other things to consider when choosing a pen needle. Talk with your health care provider; together you can decide which needle works best for you. To learn more about Novo Nordisk’s line of needles and to find the pen needle that’s right for you, click here. Today’s needles are shorter and thinner People who have never self-injected may have concerns about doing so and that’s understandable. But pen needles have come a long way from the ones first launched in 1985. Since then, injection comfort has driven needle technology, making the needles used today shorter and thinner than the ones used in the past. Understanding needle size Pen needles come in all different sizes. The size of a needle is indicated by 2 factors—length and gauge (G): Needle length is measured in millimeters. Lengths range anywhere from 12.7 mm to 4 mm, the shortest insulin pen needle currently available Understanding gauge can be a little tricky. The gauge of a needle refers to its thickness. You would think the higher the number, the thicker the needle, but it’s actually the opposite. The higher the number, the thinner the needle is. For example, a 32G needle is thinner than a 27G needle Always use a new needle for each injection You run the risk of infection from reusing needles. The more you reuse a needle, t Continue reading >>

How much insulin should I take for diabetes mellitus?

Type 1 Diabetes Mellitus Improvement of glycemic control in adults and children with diabetes mellitus May administer 0.2-0.6 unit/kg/day in divided doses; conservative doses of 0.2-0.4 unit/kg/day often recommended to reduce risk of hypoglycemia Total maintenance daily insulin requirement may vary; it is usually between 0.5 and 1 unit/kg/day; nonobese may require 0.4-0.6 unit/kg/day; obese may require 0.6-1.2 units/kg/day Type 2 Diabetes Mellitus Diabetes inadequately controlled by diet, weight reduction, exercise, or oral medication 10 units/day SC (or 0.1-0.2 units/kg/day) in evening or divided q12hr of an intermediate (eg, NPH) or long-acting insulin at bedtime recommended; conversely, regular insulin or rapid-acting insulin (aspart insulin) before meals also recommended Dosing Considerations When used in a meal-related SC injection treatment regimen, 50-75% of total insulin requirements may be provided by an intermediate-acting or long-acting insulin; the remainder is divided and provided before or at mealtimes as a rapid-acting insulin, such as insulin aspart Because of insulin aspart’s comparatively rapid onset and short duration of glucose-lowering activity, some patients may require more basal insulin and more total insulin to prevent premeal hyperglycemia than they would need when using human regular insulin Dosage must be individualized; blood and urine glucose monitoring is essential in all patients receiving insulin therapy Insulin requirements may be altered during stress or major illness or with changes in exercise, meal patterns, or coadministered drugs Dosage Modifications Patients with hepatic and renal impairment may be at increased risk of hypoglycemia and may require more frequent dose adjustment and more frequent blood glucose monitoring Continue reading >>

What is Novolog used for?

NovoLog is an insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus. NovoLog is an insulin analog with an earlier onset of action than regular human insulin. The dosage of NovoLog must be individualized. NovoLog given by subcutaneous injection should generally be used in regimens with an intermediate or long-acting insulin [ ]. The total daily insulin requirement may vary and is usually between 0.5 to 1.0 units/kg/day. When used in a meal-related subcutaneous injection treatment regimen, 50 to 70% of total insulin requirements may be provided by NovoLog and the remainder provided by an intermediate-acting or long-acting insulin. Because of NovoLogs comparatively rapid onset and short duration of glucose lowering activity, some patients may require more basal insulin and more total insulin to prevent pre-meal hyperglycemia when using NovoLog than when using human regular insulin. Warnings and Precautions (5),How Supplied/Storage and Handling (16.2)Do not use NovoLog that is viscous (thickened) or cloudy; use only if it is clear and colorless. NovoLog should not be used after the printed expiration date. NovoLog should be administered by subcutaneous injection in the abdominal region, buttocks, thigh, or upper arm. Because NovoLog has a more rapid onset and a shorter duration of activity than human regular insulin, it should be injected immediately (within 5-10 minutes) before a meal. Injection sites should be rotated within the same region to reduce the risk of lipodystrophy. As with all insulins, the duration of action of NovoLog will vary according to the dose, injection site, blood flow, temperature, and level of physical activity.NovoLog may be diluted with Insulin Diluting Medium for NovoLog for subcutaneous injection. D Continue reading >>

What is the Novolog FlexPen commercial?

NovoLog FlexPen TV Commercial, 'Vial and Syringe' Data is based on life of ad, unless indicated otherwise Data is based on life of ad, unless indicated otherwise Data is based on life of ad, unless indicated otherwise Data is based on life of ad, unless indicated otherwise About NovoLog FlexPen TV Commercial, 'Vial and Syringe' The man in this commercial says his insulin vials and syringes were getting in the way, and he didn't like having to explain what he was doing at breakfast. FlexPlen has pre-filled insulin to help control your diabetes. Well give you a glimpse of more of our powerful real-time ad analytics. Sorry, we only accept work mail accounts. Please check your email and click on the verify link it will return you right back to this page with the data unlocked. Sorry, we do not accept free email accounts. Please check your email and click on the verify link it will return you right back to this page with the data unlocked. Ready for the big time? Request a trial of the iSpot TV Ad Analytics platform. You've hit your data view limit. Time to upgrade to the full iSpot TV Ad Analytics platform. NovoLog FlexPen TV Spot, 'Vial and Syringe' Submissions should come only from the actors themselves, their parent/legal guardian or casting agency. Please include at least one social/website link containing a recent photo of the actor. Submissions without photos may not be accepted. Voice over actors: provide a link to your professional website containing your reel. Submit ONCE per commercial, and allow 48 to 72 hours for your request to be processed. Continue reading >>

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9
8.3.21PHP Version567msRequest Duration2MBMemory UsageGET {post}Route
  • warninglog[13:05:46] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\QueryFormatter:...
  • warninglog[13:05:46] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\QueryFormatter:...
  • warninglog[13:05:46] LOG.warning: Callables of the form ["Swift_SmtpTransport", "Swift_Transport_EsmtpTranspor...
  • warninglog[13:05:46] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\SimpleFormatter...
  • warninglog[13:05:46] LOG.warning: Creation of dynamic property Barryvdh\Debugbar\DataFormatter\SimpleFormatter...
  • warninglog[13:05:46] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[13:05:46] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[13:05:46] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • warninglog[13:05:46] LOG.warning: json_decode(): Passing null to parameter #1 ($json) of type string is deprec...
  • Booting (17.43ms)
  • Application (549ms)
  • 1 x Application (96.83%)
    548.84ms
    1 x Booting (3.07%)
    17.43ms
    7 templates were rendered
    • themes.DevBlog.content.post (resources/views/themes/DevBlog/content/post.blade.php)34blade
      Params
      0
      post
      1
      postContent
      2
      author
      3
      updated_at
      4
      bing_rich_snippet_text
      5
      bing_rich_snippet_link
      6
      bing_related_keywords
      7
      google_related_keywords
      8
      bing_news_title
      9
      bing_news_description
      10
      bing_videos
      11
      bing_images
      12
      bing_search_result_title
      13
      bing_search_result_description
      14
      bing_search_result_url
      15
      bing_paa_questions
      16
      bing_paa_answers
      17
      bing_slider_faq_questions
      18
      bing_slider_faq_answers
      19
      bing_pop_faq_questions
      20
      bing_pop_faq_answers
      21
      bing_tab_faq_questions
      22
      bing_tab_faq_answers
      23
      google_faq_questions
      24
      google_faq_answers
      25
      google_rich_snippet
      26
      google_search_result
      27
      indexedArray
      28
      total_images
      29
      total_videos
      30
      settings
      31
      url_current
      32
      menus
      33
      sidebar
    • themes.DevBlog.layouts.master (resources/views/themes/DevBlog/layouts/master.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.head (resources/views/themes/DevBlog/panels/head.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.header (resources/views/themes/DevBlog/panels/header.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.navbar (resources/views/themes/DevBlog/panels/navbar.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.footer (resources/views/themes/DevBlog/panels/footer.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    • themes.DevBlog.panels.scripts (resources/views/themes/DevBlog/panels/scripts.blade.php)41blade
      Params
      0
      __env
      1
      app
      2
      errors
      3
      post
      4
      postContent
      5
      author
      6
      updated_at
      7
      bing_rich_snippet_text
      8
      bing_rich_snippet_link
      9
      bing_related_keywords
      10
      google_related_keywords
      11
      bing_news_title
      12
      bing_news_description
      13
      bing_videos
      14
      bing_images
      15
      bing_search_result_title
      16
      bing_search_result_description
      17
      bing_search_result_url
      18
      bing_paa_questions
      19
      bing_paa_answers
      20
      bing_slider_faq_questions
      21
      bing_slider_faq_answers
      22
      bing_pop_faq_questions
      23
      bing_pop_faq_answers
      24
      bing_tab_faq_questions
      25
      bing_tab_faq_answers
      26
      google_faq_questions
      27
      google_faq_answers
      28
      google_rich_snippet
      29
      google_search_result
      30
      indexedArray
      31
      total_images
      32
      total_videos
      33
      settings
      34
      url_current
      35
      menus
      36
      sidebar
      37
      i
      38
      __currentLoopData
      39
      loop
      40
      item
    uri
    GET {post}
    middleware
    web, checkdate
    as
    post.show
    controller
    App\Http\Controllers\Frontend\json_data\PostController@show
    namespace
    where
    file
    app/Http/Controllers/Frontend/json_data/PostController.php:18-166
    7 statements were executed528ms
    • select * from `posts` where `published_at` <= '2025-06-17 13:05:46' and `slug` = 'how-many-units-of-insulin-are-in-a-vial-of-novolog' and `posts`.`deleted_at` is null limit 1
      2.89ms/app/Providers/RouteServiceProvider.php:54receivinghelpdeskask
      Metadata
      Bindings
      • 0. 2025-06-17 13:05:46
      • 1. how-many-units-of-insulin-are-in-a-vial-of-novolog
      Backtrace
      • 15. /app/Providers/RouteServiceProvider.php:54
      • 18. /vendor/laravel/framework/src/Illuminate/Routing/Router.php:842
      • 19. Route binding:39
      • 20. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 21. /vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:78
    • select * from `json_post_contents` where `json_post_contents`.`post_id` = 149801 and `json_post_contents`.`post_id` is not null and `rewrite_id` = 0
      4.18msmiddleware::checkdate:30receivinghelpdeskask
      Metadata
      Bindings
      • 0. 149801
      • 1. 0
      Backtrace
      • 19. middleware::checkdate:30
      • 20. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 21. /vendor/laravel/jetstream/src/Http/Middleware/ShareInertiaData.php:61
      • 22. /vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:167
      • 23. /vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
    • select * from `nova_menu_menus` where `slug` = 'header' limit 1
      370μs/vendor/outl1ne/nova-menu-builder/src/helpers.php:32receivinghelpdeskask
      Metadata
      Bindings
      • 0. header
      Backtrace
      • 15. /vendor/outl1ne/nova-menu-builder/src/helpers.php:32
      • 17. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 19. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
      • 20. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:205
    • select * from `nova_menu_menu_items` where `nova_menu_menu_items`.`menu_id` = 1 and `nova_menu_menu_items`.`menu_id` is not null and `parent_id` is null order by `parent_id` asc, `order` asc, `name` asc
      270μs/vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35receivinghelpdeskask
      Metadata
      Bindings
      • 0. 1
      Backtrace
      • 19. /vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35
      • 20. /vendor/outl1ne/nova-menu-builder/src/helpers.php:33
      • 22. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 23. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 24. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
    • select * from `nova_menu_menu_items` where `nova_menu_menu_items`.`parent_id` in (1) order by `order` asc
      260μs/vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35receivinghelpdeskask
      Metadata
      Backtrace
      • 24. /vendor/outl1ne/nova-menu-builder/src/Models/Menu.php:35
      • 25. /vendor/outl1ne/nova-menu-builder/src/helpers.php:33
      • 27. /vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 28. /vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:45
      • 29. /vendor/laravel/framework/src/Illuminate/Routing/Route.php:261
    • select `id`, `post_title`, `slug` from `posts` where `status` = 'publish' and `posts`.`deleted_at` is null order by RAND() limit 10
      519ms/app/View/Composers/SidebarView.php:22receivinghelpdeskask
      Metadata
      Bindings
      • 0. publish
      Backtrace
      • 14. /app/View/Composers/SidebarView.php:22
      • 15. /app/View/Composers/SidebarView.php:12
      • 16. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:124
      • 17. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:162
      • 20. /vendor/laravel/framework/src/Illuminate/View/Concerns/ManagesEvents.php:177
    • select * from `fake_users` where `fake_users`.`id` = 40513 limit 1
      590μsview::2dd102cf0462e89a4d4d8bc77355d767652bf9aa:15receivinghelpdeskask
      Metadata
      Bindings
      • 0. 40513
      Backtrace
      • 21. view::2dd102cf0462e89a4d4d8bc77355d767652bf9aa:15
      • 23. /vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:108
      • 24. /vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 25. /vendor/livewire/livewire/src/ComponentConcerns/RendersLivewireComponents.php:69
      • 26. /vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:61
    App\Models\FakeUser
    1
    Outl1ne\MenuBuilder\Models\MenuItem
    1
    Outl1ne\MenuBuilder\Models\Menu
    1
    App\Models\JsonPostContent
    1
    App\Models\Post
    11
        _token
        gLx3xPVN5sBIakcqV1xSxtz3iqaeXwM1vviDx7TT
        _previous
        array:1 [ "url" => "https://receivinghelpdesk.com/ask/how-many-units-of-insulin-are-in-a-vial-of-n...
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /how-many-units-of-insulin-are-in-a-vial-of-novolog
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:25 [ "cookie" => array:1 [ 0 => "_pk_id.63.7c30=299e8ed81f7492e8.1750145735.; _pk_ses.63.7c30=1; _pk_id.64.7c30=24043b10b1900fac.1750145736.; _pk_ses.64.7c30=1; XSRF-TOKEN=eyJpdiI6IjRicEdGZjhDbGpFeWJXSTBCSTZnUkE9PSIsInZhbHVlIjoiUjRIWGNnM0ZSTzdpaUZ0SW5oTS9melpRamoxOC9IVURybld5c1dkWDJ6emZlQStJNVp3UTVaRWhjNHJsanE3U1lmR0VJZENkVHQ0bjVzaXQ5VndvS2JuZ2JnWnlmZlJvTXR6OEJxNkFGbkRPUEd1Z0NXdkM3ZktQcHF5Zk84NXkiLCJtYWMiOiIzOGMyZjU4NTk5NzkyOTMzNWFkNTZkNzMzN2RhMDc5NTBmYjYxZWQwNTlkNzg5OGNlOTdhMjM3OTYwNmUyZmNhIiwidGFnIjoiIn0%3D; askhelpdesk_session=eyJpdiI6Ik4xN1ZXcHNvNUthd1JWaHhsekF1bmc9PSIsInZhbHVlIjoiV3JaUm5OMjNOMjh6QUlnaG9ERFJCMVQ1bm42eFpyVi9zT0xmSDJHWFlYUGhaVjV2MG9hNjNyS3J2UTR4OGw1K21Xb0pzVlYzU0NCZm5hM21xeU9TY3J0bDNoR1JjWnhzV0RXaitraU0rbDQrMnFscGEzdG5CQTI1UGNxTk1jY3QiLCJtYWMiOiJiYTZmYjkwNTc5MjMxN2JhNmI1NzI4ZTRiNGQ0ZDFkOWQ1M2MzOWE0MDA4MzI2NjIzN2FmYjhmMzM0Y2EzMmI4IiwidGFnIjoiIn0%3D_pk_id.63.7c30=299e8ed81f7492e8.1750145735.; _pk_ses.63.7c30=1; _pk_id.64.7c30=24043b10b1900fac.1750145736.; _pk_ses.64.7c30=1; XSRF-TOKEN=eyJpdiI6IjRicEdGZjhDb" ] "cf-ipcountry" => array:1 [ 0 => "US" ] "cf-connecting-ip" => array:1 [ 0 => "216.73.216.171" ] "cdn-loop" => array:1 [ 0 => "cloudflare; loops=1" ] "sec-fetch-mode" => array:1 [ 0 => "navigate" ] "sec-fetch-site" => array:1 [ 0 => "none" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "accept-encoding" => array:1 [ 0 => "gzip, br" ] "cf-ray" => array:1 [ 0 => "9510df444ceff14b-ORD" ] "priority" => array:1 [ 0 => "u=0, i" ] "sec-fetch-dest" => array:1 [ 0 => "document" ] "sec-fetch-user" => array:1 [ 0 => "?1" ] "cf-visitor" => array:1 [ 0 => "{"scheme":"https"}" ] "connection" => array:1 [ 0 => "close" ] "x-forwarded-proto" => array:1 [ 0 => "https" ] "x-forwarded-for" => array:1 [ 0 => "216.73.216.171, 172.70.131.140" ] "x-server-addr" => array:1 [ 0 => "154.12.239.204" ] "host" => array:1 [ 0 => "receivinghelpdesk.com" ] ]
        request_server
        0 of 0
        array:56 [ "USER" => "runcloud" "HOME" => "/home/runcloud" "SCRIPT_NAME" => "/ask/index.php" "REQUEST_URI" => "/ask/how-many-units-of-insulin-are-in-a-vial-of-novolog" "QUERY_STRING" => "" "REQUEST_METHOD" => "GET" "SERVER_PROTOCOL" => "HTTP/1.0" "GATEWAY_INTERFACE" => "CGI/1.1" "REDIRECT_URL" => "/ask/how-many-units-of-insulin-are-in-a-vial-of-novolog" "REMOTE_PORT" => "53914" "SCRIPT_FILENAME" => "/home/runcloud/webapps/ReceivingHelpDesk/ask/index.php" "SERVER_ADMIN" => "you@example.com" "CONTEXT_DOCUMENT_ROOT" => "/home/runcloud/webapps/ReceivingHelpDesk/" "CONTEXT_PREFIX" => "" "REQUEST_SCHEME" => "http" "DOCUMENT_ROOT" => "/home/runcloud/webapps/ReceivingHelpDesk/" "REMOTE_ADDR" => "172.70.131.140" "SERVER_PORT" => "80" "SERVER_ADDR" => "127.0.0.1" "SERVER_NAME" => "receivinghelpdesk.com" "SERVER_SOFTWARE" => "Apache/2.4.63 (Unix) OpenSSL/1.1.1f" "SERVER_SIGNATURE" => "" "LD_LIBRARY_PATH" => "/RunCloud/Packages/apache2-rc/lib" "PATH" => "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin" "HTTP_COOKIE" => "_pk_id.63.7c30=299e8ed81f7492e8.1750145735.; _pk_ses.63.7c30=1; _pk_id.64.7c30=24043b10b1900fac.1750145736.; _pk_ses.64.7c30=1; XSRF-TOKEN=eyJpdiI6IjRicEdGZjhDbGpFeWJXSTBCSTZnUkE9PSIsInZhbHVlIjoiUjRIWGNnM0ZSTzdpaUZ0SW5oTS9melpRamoxOC9IVURybld5c1dkWDJ6emZlQStJNVp3UTVaRWhjNHJsanE3U1lmR0VJZENkVHQ0bjVzaXQ5VndvS2JuZ2JnWnlmZlJvTXR6OEJxNkFGbkRPUEd1Z0NXdkM3ZktQcHF5Zk84NXkiLCJtYWMiOiIzOGMyZjU4NTk5NzkyOTMzNWFkNTZkNzMzN2RhMDc5NTBmYjYxZWQwNTlkNzg5OGNlOTdhMjM3OTYwNmUyZmNhIiwidGFnIjoiIn0%3D; askhelpdesk_session=eyJpdiI6Ik4xN1ZXcHNvNUthd1JWaHhsekF1bmc9PSIsInZhbHVlIjoiV3JaUm5OMjNOMjh6QUlnaG9ERFJCMVQ1bm42eFpyVi9zT0xmSDJHWFlYUGhaVjV2MG9hNjNyS3J2UTR4OGw1K21Xb0pzVlYzU0NCZm5hM21xeU9TY3J0bDNoR1JjWnhzV0RXaitraU0rbDQrMnFscGEzdG5CQTI1UGNxTk1jY3QiLCJtYWMiOiJiYTZmYjkwNTc5MjMxN2JhNmI1NzI4ZTRiNGQ0ZDFkOWQ1M2MzOWE0MDA4MzI2NjIzN2FmYjhmMzM0Y2EzMmI4IiwidGFnIjoiIn0%3D_pk_id.63.7c30=299e8ed81f7492e8.1750145735.; _pk_ses.63.7c30=1; _pk_id.64.7c30=24043b10b1900fac.1750145736.; _pk_ses.64.7c30=1; XSRF-TOKEN=eyJpdiI6IjRicEdGZjhDb" "HTTP_CF_IPCOUNTRY" => "US" "HTTP_CF_CONNECTING_IP" => "216.73.216.171" "HTTP_CDN_LOOP" => "cloudflare; loops=1" "HTTP_SEC_FETCH_MODE" => "navigate" "HTTP_SEC_FETCH_SITE" => "none" "HTTP_ACCEPT" => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" "HTTP_USER_AGENT" => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" "HTTP_UPGRADE_INSECURE_REQUESTS" => "1" "HTTP_SEC_CH_UA_PLATFORM" => ""Windows"" "HTTP_SEC_CH_UA_MOBILE" => "?0" "HTTP_SEC_CH_UA" => ""Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"" "HTTP_CACHE_CONTROL" => "no-cache" "HTTP_PRAGMA" => "no-cache" "HTTP_ACCEPT_ENCODING" => "gzip, br" "HTTP_CF_RAY" => "9510df444ceff14b-ORD" "HTTP_PRIORITY" => "u=0, i" "HTTP_SEC_FETCH_DEST" => "document" "HTTP_SEC_FETCH_USER" => "?1" "HTTP_CF_VISITOR" => "{"scheme":"https"}" "HTTP_CONNECTION" => "close" "HTTP_X_FORWARDED_PROTO" => "https" "HTTP_X_FORWARDED_FOR" => "216.73.216.171, 172.70.131.140" "HTTP_X_SERVER_ADDR" => "154.12.239.204" "HTTP_HOST" => "receivinghelpdesk.com" "HTTPS" => "on" "REDIRECT_STATUS" => "200" "REDIRECT_HTTPS" => "on" "FCGI_ROLE" => "RESPONDER" "PHP_SELF" => "/ask/index.php" "REQUEST_TIME_FLOAT" => 1750145746.6247 "REQUEST_TIME" => 1750145746 ]
        request_cookies
        0 of 0
        array:6 [ "_pk_id_63_7c30" => null "_pk_ses_63_7c30" => null "_pk_id_64_7c30" => null "_pk_ses_64_7c30" => null "XSRF-TOKEN" => "gLx3xPVN5sBIakcqV1xSxtz3iqaeXwM1vviDx7TT" "askhelpdesk_session" => "FC74mn1jz8ooRId5rZiNmPWmxirFgoqTQEMvYKV0" ]
        response_headers
        0 of 0
        array:7 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "private, must-revalidate" ] "date" => array:1 [ 0 => "Tue, 17 Jun 2025 07:35:46 GMT" ] "pragma" => array:1 [ 0 => "no-cache" ] "expires" => array:1 [ 0 => -1 ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImRkYXBWaEx0NW92OWM4WEI3WDQxY1E9PSIsInZhbHVlIjoiWHlpcU01T2RzT2I0eVloZk1qNERUUlhjKzBZMDEzZDZqZ09Ndy9PTllkVkpqcGg4STUzWXJoMzF6cE0wNjh3cW0wUDN4WXpMZlRZelVRWUJpaWZFY3g0emVFZlNLVXJQa0RxTG0wMURhQ2ZxTC85aUh3Sm9kcVpqcWR5bUZmdmgiLCJtYWMiOiIzZmE5ZDE5N2JhNjI2MmRiNWIyMTc1YjQ0MTI3ZjQwNzc4Nzk3YmUxNTg2ZDAzNDE4ZjI2NmM4NWI1OWI4MDdiIiwidGFnIjoiIn0%3D; expires=Tue, 17-Jun-2025 09:35:47 GMT; Max-Age=7200; path=/; samesite=laxXSRF-TOKEN=eyJpdiI6ImRkYXBWaEx0NW92OWM4WEI3WDQxY1E9PSIsInZhbHVlIjoiWHlpcU01T2RzT2I0eVloZk1qNERUUlhjKzBZMDEzZDZqZ09Ndy9PTllkVkpqcGg4STUzWXJoMzF6cE0wNjh3cW0wUDN4W" 1 => "askhelpdesk_session=eyJpdiI6IktjZkdFbzBNRHJ6QldaUXVWVmlyRkE9PSIsInZhbHVlIjoia1lXMHhVamtkUTZHNFhFMWxmWUt5K0UzWFBuRnQ2bVBjU0dQZGlzdDM4Y2tBcUJESERJWFp3VHlMaEFjVXNDczJ5aERpcFZnMDVMaVpwWUhnTTJkY1RyakdoT3JpMXdZbVJkWmh5U0ljeUViV2FMOFRGNlc0NzNDamZ0OWF2NGciLCJtYWMiOiJkZDMyMGE4YTRjNTMxY2VlZGVjZDdkZDhkMzYzZGViOTkzYzBmNDFmYTk3YWExYThkMGU2YzJmMDFhNzQwNzg4IiwidGFnIjoiIn0%3D; expires=Tue, 17-Jun-2025 09:35:47 GMT; Max-Age=7200; path=/; httponly; samesite=laxaskhelpdesk_session=eyJpdiI6IktjZkdFbzBNRHJ6QldaUXVWVmlyRkE9PSIsInZhbHVlIjoia1lXMHhVamtkUTZHNFhFMWxmWUt5K0UzWFBuRnQ2bVBjU0dQZGlzdDM4Y2tBcUJESERJWFp3VHlMaEFjVXND" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6ImRkYXBWaEx0NW92OWM4WEI3WDQxY1E9PSIsInZhbHVlIjoiWHlpcU01T2RzT2I0eVloZk1qNERUUlhjKzBZMDEzZDZqZ09Ndy9PTllkVkpqcGg4STUzWXJoMzF6cE0wNjh3cW0wUDN4WXpMZlRZelVRWUJpaWZFY3g0emVFZlNLVXJQa0RxTG0wMURhQ2ZxTC85aUh3Sm9kcVpqcWR5bUZmdmgiLCJtYWMiOiIzZmE5ZDE5N2JhNjI2MmRiNWIyMTc1YjQ0MTI3ZjQwNzc4Nzk3YmUxNTg2ZDAzNDE4ZjI2NmM4NWI1OWI4MDdiIiwidGFnIjoiIn0%3D; expires=Tue, 17-Jun-2025 09:35:47 GMT; path=/XSRF-TOKEN=eyJpdiI6ImRkYXBWaEx0NW92OWM4WEI3WDQxY1E9PSIsInZhbHVlIjoiWHlpcU01T2RzT2I0eVloZk1qNERUUlhjKzBZMDEzZDZqZ09Ndy9PTllkVkpqcGg4STUzWXJoMzF6cE0wNjh3cW0wUDN4W" 1 => "askhelpdesk_session=eyJpdiI6IktjZkdFbzBNRHJ6QldaUXVWVmlyRkE9PSIsInZhbHVlIjoia1lXMHhVamtkUTZHNFhFMWxmWUt5K0UzWFBuRnQ2bVBjU0dQZGlzdDM4Y2tBcUJESERJWFp3VHlMaEFjVXNDczJ5aERpcFZnMDVMaVpwWUhnTTJkY1RyakdoT3JpMXdZbVJkWmh5U0ljeUViV2FMOFRGNlc0NzNDamZ0OWF2NGciLCJtYWMiOiJkZDMyMGE4YTRjNTMxY2VlZGVjZDdkZDhkMzYzZGViOTkzYzBmNDFmYTk3YWExYThkMGU2YzJmMDFhNzQwNzg4IiwidGFnIjoiIn0%3D; expires=Tue, 17-Jun-2025 09:35:47 GMT; path=/; httponlyaskhelpdesk_session=eyJpdiI6IktjZkdFbzBNRHJ6QldaUXVWVmlyRkE9PSIsInZhbHVlIjoia1lXMHhVamtkUTZHNFhFMWxmWUt5K0UzWFBuRnQ2bVBjU0dQZGlzdDM4Y2tBcUJESERJWFp3VHlMaEFjVXND" ] ]
        session_attributes
        0 of 0
        array:4 [ "_token" => "gLx3xPVN5sBIakcqV1xSxtz3iqaeXwM1vviDx7TT" "_previous" => array:1 [ "url" => "https://receivinghelpdesk.com/ask/how-many-units-of-insulin-are-in-a-vial-of-novolog" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]